|
Originally published In Press as doi:10.1074/jbc.M102659200 on August 28, 2001
J. Biol. Chem., Vol. 276, Issue 43, 39629-39637, October 26, 2001
Kinetic Analysis of the Conjugation of Ubiquitin to Picornavirus
3C Proteases Catalyzed by the Mammalian Ubiquitin-protein
Ligase E3 *
T. Glen
Lawson §,
Molly E.
Sweep ¶,
Peter E.
Schlax ,
Richard N.
Bohnsack¶, and
Arthur L.
Haas¶
From the Department of Chemistry, Bates College,
Lewiston, Maine 04240 and the ¶ Department of Biochemistry,
Medical College of Wisconsin, Milwaukee, Wisconsin 53226
The 3C proteases of the
encephalomyocarditis virus and the hepatitis A virus are both type III
substrates for the mammalian ubiquitin-protein ligase E3 . The
conjugation of ubiquitin to these proteins requires internal ten-amino
acid-long protein destruction signal sequences. To evaluate how these
destruction signals modulate interactions that must occur between E3
and the 3C proteases, we have kinetically analyzed the formation of
ubiquitin-3C protease conjugates in a reconstituted system of purified
E1, HsUbc2b/E214Kb, and human E3 . Our
measurements show that the encephalomyocarditis virus 3C protease is
ubiquitinated in this system with Km = 42 ± 11 µM and Vmax = 0.051 ± 0.01 pmol/min whereas the parameters for the ubiquitination of the
hepatitis A virus 3C protease are Km = 20 ± 5 µM and Vmax = 0.018 ± 0.003 pmol/min. Mutations in the destruction signal sequences resulted in
changes in the rate at which E3 conjugates ubiquitin to the altered
3C protease proteins. The Km and
Vmax values for these reactions change
proportionally in the same direction. These results suggest differences
in rates of conjugation of ubiquitin to 3C proteases are primarily a
kcat effect. Replacing specific
encephalomyocarditis virus 3C protease lysine residues with
arginine residues was found to increase, rather than decrease, the rate
of ubiquitin conjugation, and the Km and
Vmax values for these reactions are both higher
than for the wild type protein. The ability of E3 to catalyze the
conjugation of ubiquitin to both 3C proteases was found to be inhibited
by lysylalanine and phenylalanylalanine, demonstrating that the same
sites on E3 that bind destabilizing N-terminal amino acids in type I
and II substrates also interact with the 3C proteases.
*
This work was supported in part by National Science
Foundation Research in Undergraduate Institutions Award
MCB-9974497 (to T. G. L.), a Henry Dreyfus Teacher Scholar Award (to
T. G. L.), a Roger C. Schmutz Faculty Research Grant (to
T. G. L.), and by United States Public Health Services Grant GM 34009 (to A. L. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 207-786-6293;
Fax: 207-786-8336; E-mail: tlawson@bates.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Eldin, L. Papon, A. Oteiza, E. Brocchi, T. G. Lawson, and N. Mechti
TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus
J. Gen. Virol.,
March 1, 2009;
90(3):
536 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Siepmann, R. N. Bohnsack, Z. Tokgoz, O. V. Baboshina, and A. L. Haas
Protein Interactions within the N-end Rule Ubiquitin Ligation Pathway
J. Biol. Chem.,
March 7, 2003;
278(11):
9448 - 9457.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|